Onto Innovation (ONTO) Posted A Record Quarter, Is It Still 26% Undervalued?
Onto Innovation (ONTO) has given investors a fresh set of numbers to work with after reporting a record quarter, supported by 35.3% revenue growth and a backlog above US$1b.
Onto Innovation’s record quarter and the recently closed US$720 million minority stake in Rigaku align with a powerful share price run, with a 1-year total shareholder return of 169.75% and a year-to-date share price return of 69.48%. However, the 30-day share price return is down 8.82%, suggesting strong longer-term momentum with some near-term cooling after a sharp move higher.
Scan beyond Onto Innovation and see how other chip-related players with strong demand setups are lining up in the 55 AI infrastructure stocks.
Onto Innovation’s sharp pullback over the past month sits against a powerful multi-year run and record operating metrics. Is the recent surge mostly business catching up to price, or is price running ahead of fundamentals?
Most Popular Narrative: 26% Undervalued
The most followed Onto Innovation narrative marks out a fair value of $380 against the last close of $281.11, framing the recent pullback as a gap between price and story.
Onto Innovation is emerging as one of the most strategically important semiconductor equipment companies in the AI supply chain. While much investor attention remains focused on GPU manufacturers and memory suppliers, the next bottleneck increasingly lies in advanced packaging, the complex process of stacking, connecting, and inspecting AI chips and HBM memory at nanometer precision.
Read the complete narrative. Read the complete narrative.
Want to understand why this fair value sits well above today’s share price? The narrative leans heavily on ambitious earnings expansion, richer margins and premium-like multiples tied to AI packaging demand. Curious which assumptions around advanced packaging volumes and profitability need to land for that $380 figure to hold up?
Result: Fair Value of $380 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Onto Innovation story can break if AI related capex or HBM tool orders undershoot expectations, or if a larger rival undercuts Dragonfly in advanced packaging.
Find out about the key risks to this Onto Innovation narrative.
Another View: Pricing Onto Innovation Off Earnings
The $380 fair value story leans heavily on future earnings power and richer multiples. Looking at where Onto Innovation trades today, the P/E of 104x is more than double both the US Semiconductor industry at 47.2x and peer average at 45.6x, and also well above a fair ratio of 46.2x. That gap points to meaningful valuation risk if expectations around AI packaging ease back or timing slips. Does that premium feel like a cushion or more like a tightrope?
For investors who prefer to anchor decisions to current earnings and relative pricing, our valuation breakdown based on this P/E gap can help frame how much sentiment is already embedded in the stock. See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Many Onto Innovation watchers will see both excitement and tension in this setup, so move fast on the data and test your own thesis with the 3 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Onto Innovation?
Do not stop with Onto Innovation. Broaden your watchlist with fresh ideas that match your style so you are not relying on a single story.
- Hunt for quality at a discount and scan a curated pool of underpriced opportunities using the 49 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies that combine higher yields with resilience through the 6 dividend fortresses.
- Reduce portfolio stress and focus on resilience by filtering for companies with steadier profiles via the 82 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com